News

Inicio|News
News2020-07-06T12:01:15+00:00

julio 2020

CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections

Por |julio 7th, 2020|Categorías: News|

Vaxdyn’s new vaccine against Gram-negative pathogens, if approved, would help

Comentarios desactivados en CARB-X is funding Spanish biotech Vaxdyn to develop a new vaccine to prevent superbug infections that cause life-threatening pneumonia and other deadly infections